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The cellular immune responseto the AIDS virus remains poorly understood. The
cell-mediated immune response to virus infection usually involves the generation
ofantigen-specific CD8+ lymphocyte populations. One subset ofthese CD8+ cells,
the CTL, lyres virus-infected MHC class 1-matched target cells (1) using the CD8
molecule (2). Studies have indicated that a CD3+CD8+ cell in PBL of HIV-1-in-
fected individualsexists that lyses HIV-1 antigenexpressing target cells in an MHC
class I-restricted fashion (3-5). What role this cell actually plays in controlling an
HIV-1 infection is unclear. CD8' lymphocytes have also been shown to be capable
ofblockingreplication ofHIV-1 in PBL ofinfectedindividuals (6). These cells could
clearlybeimportant in containing thereplication ofHIV-1 in the infected individual.
The functional subset oflymphocytes to which this virus inhibitory cell population
belongs and its relationship to CTL have not been defined.
The simian immunodeficiency virus of macaques (SIVmac)' is homologous in its
nucleotide sequence to HIV-1 and HIV-2 (7, 8)and inducesAIDS in rhesus monkeys
(9). The remarkable similarities in the in vitro and in vivo biological properties of
HIV-1 and SIVmac make the rhesus monkey/SIVmac system an important animal
model for the study of AIDS (10-13). In developing the rhesus monkey/SIVma,
system as a model for AIDS vaccine assessment, we have been studying the role
ofthe CD8+ lymphocyte ofthe rhesus monkey in the immune response to SIVmac.
We have shown that a CD8' lymphocyte can block SIVmac replication in PBL of
infected monkeys (14).
In the present experiments, we haveperformed parallel studiesofthe cell-mediated
immune response to both SIVmac and HIV-1, characterizing the CD8+ cell that in-
hibits SIVmac and HIV-1 replication in PBL. These experiments suggest that the cell
that inhibits AIDS virus (by this we mean both SIVmac and HIV1) replication is
a CTL.
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Materials and Methods
Lymphocyte Preparation and Cell Cultures.
￿
Heparinized blood samples were obtained from
rhesus monkeys (Maraca mulatta) that had been experimentally infected with SIVma, isolate
251 and clinicallyhealthy HIV-1-infected humanvolunteers. PBL were isolated from the blood
by Ficoll-diatrizoate density gradient centrifugation and activated with 10,ug/ml Con A (Difco
Laboratories, Detroit, MI) for 3 d. These cells were then maintainedin RPMI 1640 medium
supplemented with 10% FCS (FlowLaboratories, McClean, VA), L-glutamine (2 mM), pen-
icillin (50 U/ml), gentamycin (50 ug/ml), and 2 U/ml rIL-2 (provided by E. I. DuPont de
Nemours & Co., Wilmington, DE). Cell concentration was regularly adjusted to 1.5 x
106/ml.
CD8' Lymphocyte Depletion.
￿
CD8` cells were depleted from Con A-activated PBL by the
panning method. PBL were incubated at a concentration of 1.5 x 10'/ml for 40 min at 4'C
with anti-CD8 mAb (7PT3F9; provided by S. Schlossman, Dana-Farber Cancer Institute,
Boston, MA) in ascites form at a dilution of 1 :125. The cells were then washed twice with
PBS and resuspended in PBS at a concentration of 4 x 106 cells/ml. 3 ml of this cell suspen-
sion were plated on a 10-cm plastic petri dish coated with 10 p,g rabbit anti-mouse Ig (Dako
Corp., SantaBarbara, CA) and preincubated with 10 ml of PBS supplemented with 2 % FCS
(Flow Laboratories). Cells were incubated on these dishes for 70 min at 4°C. The dishes
were then swirled and cells in the supernatant were harvested. These cells were used as a
CD8' cell-depleted population. Cells adherent to the dishes were recovered and used as
CD8' lymphocyte-enriched populations.
Anti-CD4 Blocking of Virus Replication in PBL ofSIV~ and HIV-1-infected Individuals.
￿
CD8'
cell-depleted lymphocytes were prepared from Con A-activated PBL by the panning method.
Aliquots of these cells were incubated at various times during the period of culture with a
1 :100 dilution of ascites of anti-CD4 mAb (19Thy5D7, S. Schlossman) for 30 min at room
temperature at a concentration of 2 x 106/ml. Cells were maintained in RPMI 1640 medium
supplemented with 10% FCS and IL-2. The anti-CD4 mAb ascites was added to the cultures
after this incubation at a final concentration of 1 :400 for defined periods of time.
Preparation of CD8'2H4+ and CD8'2H4- Cell Subpopulations.
￿
CD4' cells were eliminated
from Con A-activated PBL by the technique of complement-dependent lysis. PBL at a con-
centration of 10'/ml were incubated with a 1 :200 dilution of anti-CD4 mAb (19Thy5D7) as-
cites for 30 min at room temperature. Rabbit complement (Pet-Freeze Biologicals, Brown
Deer, WI) at a final concentration of 1:8 and 2 .5 wg/ml of DNase (Sigma Chemical Co., St.
Louis, MO) were then added to the cell suspension. Cells were then incubated on a shaker
for 30 min at 37"C. After a total incubation of 1 h, cells were pelleted by centrifugation and
supernatant was discarded. The same procedure was repeated two more times and the cells
were then washed three times with PBS. The resulting CD4' cell-depleted PBLs (<3% CD4'
and >90% CD8' cells as determined by flow cytometric analysis) were separated into 2144'
and 2144- cell fractions by the panning method using the anti-2144 mAb (C. Morimoto).
Depletion ofNK Cellsfrom PBL.
￿
Complement-dependent lysis was performed to deplete
NK cells from Con A-activated PBL. Anti-NKHIA (provided by J. Ritz, Dana-Farber
Cancer Institute) and anti-Leullb (anti-CD16; Becton-Dickinson & Co., Mountain View,
CA) were used for these treatments. An irrelevant mAb (5E5C) and an anti-CD8 mAb
(7PT3F9) were also used to prepare control cell populations.
Functional Blocking Experiments with mAbs.
￿
Anti-CD8 (21Thy2D3, 7PT4F12, 7PT3F9,
lmono2E7, S. Schlossman; 6F7, 6B7, C. Morimoto; MT122, P Rieber, University of Munich,
Munich, FRG); anti-CD2 (3PT2H9, S. Schlossman); anti-CD11a(2F12, J. Ritz); anti-CD11b
(904, S. Schlossman); and an irrelevant mAb (5E5C) were used. Con A-activated PBL were
incubated with a 1 :100 dilution of ascites of each mAb for 30 min at room temperature at
a concentration of 10'/ml, then maintained in the continuous presence of the same antibody
at a dilution of 1 :400. Reverse transcriptase (RT) activity of the supernatants was regularly
monitored.
Flow CytometricAnalysis.
￿
For the two-color analyses, 106 cells were incubated with the first
mAb (a 1 :400 dilution of ascites of anti-S6F1 [C. Morimoto], -2114 or -NKH1A) for 40
min at 4°C, then washed and incubated with the second antibody (FITC-conjugated
goat-anti-mouse IgG [Tago Inc., Burlingame, CA] for anti-S6F1 and anti-2114; FITC-conjugated goat anti-mouse I9M [Tago Inc.] for anti-NKHIA) for 40 min at 4°C. Cells were
washed with PBS and then incubated with the third antibody (phycoerythrin [PE]-conjugated
anti-CD4, OKT4-RDI; PE-conjugated anti-CD8, OKT8-RDI; Ortho Diagnostic Systems,
Raritan, NJ; PE-conjugated-anti-4114, Coulter Immunology, Hialeah, FL). After washing
with PBS, cellswere resuspended in PBS or 1.0% formalin-PBS (cells from infected individ-
uals were resuspended in 1 .0% formalin-PBS and left overnight to inactivate virus). Flow
cytometric analyses were performed on an EPICS-CS (Coulter Electronics, Hialeah, FL).
Cells were also first reacted with an irrelevant antibody to demonstrate the specificity of the
staining shown with the other antibodies.
RT Assay.
￿
RT assays were performed as previously described (10).
One-Dimensional Isoelectric Focusing(1-D IEF)Analysis ofMHC ClassI Glycoproteins.
￿
1-D IEF
studies were performed on lectin-activated PBL of rhesus monkeys as previously described
(15, 16). In brief, PBL were biosynthetically labeled with ["S]methionine and lysed. Lysates
were phaseseparated, precleared, and MHC class I molecules were immunoprecipitated with
the mAb BB7.7 (17). Neuraminidase-treated samples were subjected to 1-D IEF; the pH gra-
dient across the gel was approximately pH 5-7.
Results
CD8+ Lymphocytes Inhibit SIV ., Replication in PBL of Infected Monkeys.
￿
We first
sought to define the cell population in PBL of SIVmac-infected rhesus monkeys
which inhibits SIVnac replication. As shown in Fig. 1, Con A-activated PBL of
SIVnac-infected, clinically healthy monkeys maintained in culture in the presence
of IL-2 do not generate RT activity. This indicates that virus replication is not oc-
curring. However, after depletion of CD8 + cells from those lymphocytes, viral repli-
cation is easily demonstrated. The addition of autologous CD8' cells to these CD8+
lymphocyte-depleted PBL inhibits this virus replication. Thus, as described for HIV-1
by Walker et al. (6), SIVmac replication in PBL of rhesus monkeys is inhibited by
autologous CD8+ lymphocytes.
In Vitro AIDS Virus Replication in PBL ofInfected Humans or Monkeys Is Perpetuated
by Cell-to-Cell Spread of Virus. Virus replication in such CD8+ lymphocyte-depleted
PBL could result either from uninhibited replication in a large number of previ-
ously infected cells or an infection spreading to previously uninfected cells from a
limited number of cells. Since anti-CD4 antibody should block the spread of infec-
tious virus from one cell to another, inhibition of replication by addition of anti-
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FIGURE 1.
￿
Autologous CD8' lymphocytes inhibit the gener-
ation of RT activity in vitro in CD8' lymphocyte-depleted
PBL from SIVmac-infected rhesus monkeys. AfterCon A acti-
vation, PBL were left unfractionated (O) or CD8' lympho-
cyteswere depleted by the technique of panning(*) and cells
were then maintained in IL-2-supplemented culture medium. .
5 x 105 autologous CD8' lymphocytes were added back (A)
to 5 x 105 CD8' lymphocyte-depleted cells in a 2-ml volume.
RT activity was regularly assessed in the culture medium as
a measure of virus replication.1424
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CD4 would indicate that infection is propagated under these culture conditions by
spread from infected cells to uninfected cells. CD8' lymphocyte-depleted PBL from
an SIVnac-infected monkey were Con A activated and then maintained in IL-2-
supplemented medium in the absence of mAbs or in the continuous presence of an
irrelevant mAb, an anti-CD4 mAb or with the anti-CD4 mAb added on day 3 or
day 10 of culture (Fig. 2 A). While SIVmac replication occurred in the absence of
mAb and in the presence of an irrelevant mAb, all detectable replication was in-
hibitedwhen anti-CD4 antibody was added on day 3 of culture. Moreover, ongoing
replication was blocked by the addition of anti-CD4 mAb to the cells on day 10 of
culture. Similar results were seen in parallel studies of CD8' lymphocyte-depleted
PBL of HIV-1-infected humans (Fig. 2 B). Notonly did the addition of an anti-CD4
mAb on day 12 of culture block ongoing HIV-1 replication, but the removal of the
anti-CD4 mAb on day 8 from the cultures continuously exposed to anti-CD4 anti-
body resulted in a delayed initiation of detectable HIV-1 replication in these PBL.
Thus, in vitro replication of both SIV.ac and HIV-1 in CD8' lymphocyte-depleted
PBLof infected individuals appearsto reflect spread of infectious virusfrom alimited
number of cells to the otherIL-2-driven lymphocytes. The CD8' lymphocyte may,
therefore, be capable of inhibiting the cell-to-cell spread of infectious virus.
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FIGURE 2. (A) Anti-CD4 antibody blocks virus replication in
CD8' lymphocyte-depleted PBLs of an SIVmac-infected monkey.
(B)Anti-CD4 antibody blocks virus replication in CD8' lympho-
cyte-depleted PBL of an HIV-1-infected human. PBL were ob-
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tained from a SIVmac-infected rhesus monkey (A)and HIV-1 in-
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￿
fected human (B). CD8` cells were depleted by the panning
method. (A)Monkey PBLwere maintained in theabsenceofmAb
(O), or reacted with and maintained in the presence ofan irrele
vant mAb during d3-d20 ("), anti-CD4 during days 3-20 (A),
or anti-CD4 during days 10-13 (p). (B)HumanPBLs were main-
tained in theabsenceofmAb(O), or reactedwith andmaintained
in the presence ofanti-CD4 during d3-d25 (X), during d3-d8(A),
or during d12-dl5 (/).
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CD8' Inhibitory Lymphocytes Are Detectable only Weeks after SIV. Infection.
￿
We ini-
tially sought to determine whether the CD8` cells that inhibit AIDS virus replica-
tion in PBL of infected individuals have characteristics of antigen-specific lympho-
cytes. Detection ofthese cells in PBL of rhesus monkeys immediately after infection
with SIVmac would be consistent with their being NK cells. Their detection in
monkey PBL only after a period of weeks after virus infection would suggest that
they may undergo clonal expansion and might, therefore, be antigen specific. Four
normal rhesus monkeys were experimentally inoculated with SIVmac and their CD8'
PBL were assessed for inhibition of SIVmac replication. Such an inhibitory cell popu-
lation was not detectable in PBL ofany ofthe four animals 1 wk after infection (data
not shown). As summarized in Table I, this CD8' cell population was detectable
in one of the four animals at 13 d after infection, in three of the four animals at
30 d after infection and in all of the animals 60 and 90 d after infection. This obser-
vation suggests that a clonal expansion of the CD8' cell population capable of in-
hibiting viral replication may occur in the initial weeks after infection. Thus, these
CD8' cells may be antigen specific rather than an NK cell population.
The CD8' Lymphocyte That Inhibits AIDS Virus Replication Is not a NK Cell.
￿
The
possibility that the cell that inhibits AIDS virus replication in vitro might be a NK
cell was then investigated. Virus replication was assessed in NK cell-depleted PBL
from SIVmac-infected, clinically healthy rhesus monkeys. These PBL were treated
with anti-CD8, anti-NKH1, or anti-CD16 and complement and then maintained
in IL-2-supplemented medium. As shown in Table II, SIVmac replication was
demonstrated in CD8' lymphocyte-depleted, but not in NKH1' or CD16' lym-
phocyte-depleted PBL. Similar results were observed in parallel studies of PBL from
HIV-1-infected humans (Table III). These studies suggest that the CD8' cell that
inhibits SIVmac and HIV-1 replication in vitro does not express NK cell-associated
surface antigens.
TABLE I
Time after Virus Inoculation of Generation of CD8'
AIDS Virus Inhibitory Response
' Peak RT activity (cpm/ml) of CD8' cell depleted culture supernatant
Peak RT activity (cmp/ml) of unfractionated PBL culture supernatant
t Ratio calculated as shown, with larger number indicating more pronounced CD8' cell in-
hibitory response.
Animal 13
Days after
30
infection
60 90
Mm129-86
101,561
`(1 .7)1
39,896
(2.0)
16,574
(4. 2)
22,992
(8.0)
60,870 19,091 3,959 2,860
Mm161-86
45,970
(20.6)
35,922
(5.3)
14,344
(14.6)
14,592
(27.2)
2,229 6,772 986 537
Mm179-86
34,019
(2.6)
1,352
(5.3)
1,611
(10.9)
3,800
(25.5)
13,060 255 148 149
Mm244-86
6,173
(1 .2)
7,154
(14.2)
6,123
(8.2)
3,956
(12.3)
5,342 504 751 3221426
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TABLE II
Virus Replication in PBL of SIV~-infected Rhesus Monkeys
after Elimination of NK Cells
' Determined by flow cytometric analysis.
i Irrelevant mAb.
CD8' Lymphocytes Inhibit SIV ,a, Replication in Autologous but not in MHC Class (-
mismatched Lymphocytes. The interactions ofantigen-specific CD8+ lymphocytes are
restricted by MHC class I surface molecules. We, therefore, sought to determine
whether the interactions of the SIVmac inhibitory CD8' cell population of the rhesus
TABLE III
Virus Replication in PBL of HIV-1-infected Humans
after Elimination of NK Cells
' Determined by flow cytometric analysis.
1 Irrelevant mAb.
§ Not determined because of insufficient numbers of cells.
Treatment with
complement and
Positive
Before
treatment
cells'
After
treatment day 11
RT activity
day 17 day 21
cpm/ml
Volunteer No. 28
Negative Abl 1 1 413 579 496
Anti-CD8 28 4 1,262 6,288 6,823
Anti-NKH1 17 <1 613 182 144
Anti-CD16 9 <1 463 252 160
Volunteer No. 29
Negative Ab ND4 ND 579 1,054 748
Anti-CD8 ND ND 16,034 3,318 1,323
Anti-NKHI ND ND 1,064 2,752 767
Anti-CD16 ND ND 709 1,257 2,681
Volunteer No. 30
Negative Ab 1 1 533 600 472
Anti-CD8 38 2 415 5,736 2,131
Anti-NKHI 11 <1 389 343 327
Anti-CD16 9 3 300 154 330
Treatment with
complement and
Positive
Before
treatment
cells'
After
treatment day 11
RT activity
day 17
cpm/ml
day 24
Mm 161-86
Negative Ab1 2 1 657 455 702
Anti-CD8 54 3 935 1,936 42,293
Anti-NKH1 5 <1 789 475 503
Anti-CD16 4 <1 468 742 231
Mm244-86
Negative Ab 1 1 559 378 502
Anti-CD8 39 1 15,334 24,757 12,706
Anti-NKHI 4 <1 652 451 242
Anti-CD16 4 1 691 632 362TSUBOTA ET AL .
￿
1427
FIGURE 3 .
￿
(A) PBL from animals 51
and249 expressdifferentMHCclass I
molecules than PBLs of animal 434.
Lysates of [35S]methionine-labeled
rhesus monkey PBL were phase sepa-
rated, precleared, and MHC class I
molecules were immunoprecipitated .
After neuraminidase treatment, sam-
ples were subjected to 1-D IEF anal-
ysis. The position of li -2 microglobulin
(li-2) is indicated. (B) Autologous, but
notMHC class I mismatched, CD8'
lymphocytes inhibit the generation of
RT activity in vitro in CD8' lympho-
cyte-depleted PBL from SIV-cin-
fected rhesus monkeys . CD8' cells
from monkey 434 (O), 249 (/) or 51
(A) were added to CD8' lympho-
cyte-depletedPBL ofmonkey 434 (" )
and cultures were maintained in IL-2-
containing medium . RT activity was
regularly assessed in the culture
medium as a measure of virus repli-
cation .
monkey areMHC class I restricted . BecauseMHC typing sera for rhesus monkeys
arenotwidely available and are incomplete in thespectrum ofspecificities they define,
we used 1-D IEF to characterize the MHC class I phenotype of clinically healthy
SIVmac-infected rhesus monkeys. As shown in Fig. 3 A, studies of this type yield
a distinct bandingpatternon a 1-DIEFgelforeach animal, every band representing
adifferentMHC class I allelic product . AlthoughMHC classI-matched, unrelated
SIVmac-infected monkeys were not available for study, MHC class I-disparate in-
fected animals could be readily defined . Animals 51, 249, and 434 differed in their
expression of MHC class I alleles . Con A-activated CD8' lymphocyte-depleted
PBL from rhesus monkey 434 were maintained in culture in the presence of IL-2 .
As shown in Fig. 3 B, virus replication occurred in the absence of reconstitution
with CD8' lymphocytes, and was inhibited with the addition of autologous CD8'
cells. The addition ofMHC class I-mismatched populations of CD8' cells from
SIVmac-infected animals 249 or 51 failed to inhibit virus replication . These mis-
matched CD8' cell populations inhibited SIVmac replication in autologous CD8+
lymphocyte-depleted PBL (data not shown) . Therefore, MHC class I-mismatched
CD8' cells do notinhibit the in vitro replication of SIVmac under these culture con-
ditions .
TheAIDS Virus Inhibitory Cells Area Phenotypically Distinct Subpopulation ofCD8+ PBL .
We further characterized the CD8' cell that inhibits SIVmac and HIV -1 replication
by determining whether the virus inhibitory activity resides in all CD8` cells or in
a subpopulation of phenotypically distinct CD8' cells. In pursuing these studies,
wemade use ofthe observation that recently defined surface antigens are expressed1428
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on functionally distinct subpopulations of human and rhesus monkey CD8' lym-
phocytes. The antigens assessed in these studies included 2H4, 4B4, and S6F1. 2H4
is a member of the T200 family of molecules (18), 4B4 is a member of the integrin
family ofcell surface molecules(19), and S6F1 is an epitope ofthe cell adhesion mol-
ecule LFA-1 (20). As shown in Figure 4 A, human CD8' PBL (and rhesus monkey
CD8+ PBL; data not shown) can be fractionated into mutually exclusive 4B4+2H4-
and 4B4-2H4' subpopulations. Moreover, as shown in Fig. 4 B, the CD8+4B4+
human lymphocytes also express S6F1.
CD8+ lymphocytes were prepared from PBL of an HIV-1-infected, clinically
healthy human and fractionated by the panning method into 2H4+ and 2H4- sub-
populations. These subpopulations of CD8' cells were then added to CD8+ lym-
phocyte-depleted autologous PBL andRT activity in the supernatants of theserecon-
stituted cultures was monitored. As shown in Fig. 5 B, the unfractionated CD8'
lymphocytes significantly inhibited RT activity in autologous CD8' lympho-
cyte-depleted PBL. While the 4B4- S6F1 -2H4+ subpopulation of CD8+ lympho-
cytes had no HIV-1 inhibitory activity, the 4B4+S6F1 + 2H4- subpopulation totally
inhibited HIV-1 replication in vitro. An analogous experiment was done usingsimi-
larly prepared subpopulations of CD8' lymphocytes from SIVIpac-infected, clinically
healthy rhesus monkeys. As shown in Fig. 5 A, virtually no inhibitory activity was
observed in the CD8' cell subpopulation that was 4B4-2H4* . However, complete
inhibition of RT activity was seen in cultures reconstituted with CD8+ 4B4+ 2H4-
cells. Thus, both in PBL of HIV-1-infected humans and SIVnac-infected rhesus
monkeys, viral replication was inhibited by a subpopulation of CD8' lymphocytes.
Since 4B4 is a member of the integrin family of molecules, molecules involved
in cell adhesion, these findings suggested that cell contact might occur between the
virus inhibitory cell and the cell harboring viral replication . Moreover, S6F1 has
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FIGURE 4.
￿
(A) CD8' human PBL comprise mutually exclusive 2H4*4B4- and 2H4-4B4+ sub-
populations. (B) CD8+4B4* human PBL express the surface antigen S6F1. CD8' cells were en-
riched by the panning method. These lymphocytes were depleted of residual CD4* cells 2 d later
by antibody and complement lysis. Cells were then reacted with the described antibodies. The
horizontal scale indicates red fluorescence and the vertical scale indicates green fluorescence.TSUBOTA ET AL.
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FIGURE 5.
￿
CD8* 4B4'S6F1'2H4- cells but not CD8* 4B4-S6F1-2H4* cellsinhibit virusrepli-
cation in CD8* lymphocyte-depleted PBL of a rhesus monkey infected with SIV_ (A) and a
human infected with HIV-1 (B). CD8* lymphocyte-depleted PBL were prepared by the pan-
ning method and maintained alone (O), reconstituted with an equal number ofunfractionated
CD8* cells ("), CD8* 4B4'S6F1'2H4- cells (/) or CD8* 4B4-S6F1 -2H4* cells (A).
recently been shown to be expressed by CD8* cytotoxic effector but not CD8* sup-
pressor effector lymphocytes (19). This phenotypic characterization of the CD8*
lymphocytes that inhibit AIDS virus replication in vitro suggested that the cell that
inhibits viral replication may, in fact, be a CTL that must come into direct physical
contact with its target cells in vitro.
Cell-to-Cell Contact Is Requiredfor CD8' Lymphocyte-mediated Inhibition ofAIDS Virus
Replication. We then examined the cell interactions leadingto the inhibition of viral
replication, assessing the possible importance of cell contact in these interactions.
Anti-LFA-1 antibodies have been shown to inhibit killer effector-target adhesion (21).
Lectin-activated PBL from a clinically healthy HIV-1-infected human were placed
in culture in IL-2-supplemented medium in the presence of two irrelevant mAbs
or in the presence of an anti-LFA-la mAb (Fig. 6). While no virus replication was
seen in theabsence ofamAb or in the presence of irrelevant mAbs, viral replication
was readilydemonstrated in theculture maintained in the presence of the antiLFA-1ct
mAb. (These studies were not done on PBL from SIVnnac-infected monkeys because
this anti-LFA-1a mAb does not react with rhesus monkey cells.) This finding sug-
gested that direct cell contact is required between the CD8* lymphocyte and its
target cell in vitro for inhibition of viral replication to occur.
We further characterized the lymphocyte that inhibits SIVmac replication by ex-
amining the role of the CD8 molecule in this inhibitory process. Anti-CD8 mAbs
have been shown to block theeffector function of both allo-specific and virus-specific
CTL(2, 22). Ifthe CD8 molecule were specifically involved in theinhibition ofvirus
replication, mAbs directed against critical epitopes of the CD8 structure might be
expected to inhibit the ability of the CD8* lymphocytes to subserve their inhibi-1430
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￿
Virusreplication is facilitated in PBL
of an HIV-1-infected humanby an anti-LFA-1 an-
tibody. ConA-activated PBL from an HIV-1 in-
fected humanwere maintained in culturewithout
mAb (O), with anti-CD11a (LEA-1a; N) anti-
CD116(Mol; A), andanti-CD2 antibody (X). RT
activity was regularly assessed in the culture
medium as a measure of virus replication.
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FIGURE 7.
￿
Virus replication is facilitated in PBL of a SIVma,infected rhesus monkey (A) or
HIV-1-infected human (B) by anti-CD8 mAb. Con A-activated PBL from a SIVm_ infected
monkey or HIV-1-infected human were maintained in IL-2 containing medium. (A) Monkey
PBL were maintained in the presence of an irrelevant control mAb (O), and anti-CD2 mAb
(3PT2H9)(/)or oneoftwoanti-CD8 monoclonal antibodies, 7PT4Fl2(0)or 6F7(A). Monkey
PBL maintained in the presence of oneother anti-CD8 antibody (7PT3F9) didnot generate RT
activity (data not shown) (B) Human PBL were maintained in the absence of a mAb (O), in
the presence of an irrelevant control monoclonal antibody (A), or one of two anti-CD8 mAbs:
21Thy2D3 ("), or MT122 (X). RT activity was regularly assessed in the culture medium as a
measureof virus replication. Human PBLmaintained in thepresence ofthreeotheranti-CD8
antibodies (7PT4F12, 6F7, 1Mono2E7) did not generate RT activity (data not shown).TSUBOTA ET AL.
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tory function. As shown in Fig. 7 A, while Con A-activated unfractionated PBL
from SIVac-infected monkeys did not generate significant RT activity when main-
tained in culturewith an irrelevant oran anti-CD2 mAb, virus replicationoccurred
ifthese cultured PBL were maintained in the presenceofan anti-CD8 mAb. Thus,
the addition ofcertain anti-CD8 mAbs to PBL from SIVma,-infected monkeys in
vitro blocked the inhibitory function of the CD8+ lymphocytes.
We then sought to determine the relevance ofthis observation for the control of
HIV-1 replication in human PBL. As previously shown in the SIVma, system, virus
replication was not detected in Con A-activated PBL of clinically healthy, HIV-1-
infected humans. HIV-1 replication was, however, detected after CD8+ lymphocyte
depletion (data not shown). Importantly, when the function of the CD8 molecule
was blocked by certain anti-CD8 mAbs, these CD8+ T lymphocytes were no longer
capable ofinhibiting virus replication (Fig. 7 B). Thus, the CD8 molecule appears
to play a crucial role in the cell-cell interactions that result in the inhibition ofboth
SIVma, and HIV-1 replication in vitro.
Discussion
These studies characterize a PBL population from AIDS virus-infected individ-
uals capable of inhibiting AIDS virus replication. These cells were shown to be
CD8', undergo clonal expansion in vivo after AIDS virus infection of the in-
dividual, and block replication of virus in autologous but not MHC class I-mis-
matched PBL. These cells express membrane structures that are involved incell adhe-
sion andtheirabilitytoinhibitvirus replication canbeblocked withmAbs that interfere
with physical contact between the CD8+ lymphocytes and their target cells.
Several lines ofevidence establish that the AIDS virus inhibitory CD8' lympho-
cyte in PBL of infected individuals is not a NK cell. Depletion from PBL of cells
expressing the NK-associated antigens NKH1 and CD16did not facilitate virus repli-
cation in cultures. The inhibition ofAIDS virus replication was alsoblockedby anti-
CD8 mAbs. Inother experimental systems, anti-CD8 mAbs, while inhibiting CTL
effector function, do not inhibit NK activity (2, 23). Finally, in the current studies,
the CD8' lymphocyte-depleted cells that support virus replication, even at the time
ofpeak AIDS virus replication, contain a substantial number ofNKH1' cells (data
not shown).
Since these virus inhibitory CD8' lymphocytes are not NK cells, they are likely
to be antigen specific. We have previously shown that CD8' cells capable of in-
hibiting AIDS virus replication are present in PBL of infected but not uninfected
individuals (14). We have now demonstrated that a period ofweeks is required after
infection for a maturation ofthe CD8' lymphocyte-mediated inhibitory response.
We also have previously shown that cell lines that exhibit this inhibitory function
can be established in vitro by stimulating PBL from SIVmacinfected monkeys with
autologous SIV ..a, antigen-expressing cells in the presence ofIL-2 (14). It will, how-
ever, be necessary to show that the CD8' cells that inhibit virus replication can be
generated by specific antigen priming orthat such cells isolated from infected indi-
viduals have specific proliferative activity after AIDS virus antigen stimulation to
establish conclusively that they are indeed antigen specific.
Antigen-specific CD8' lymphocytes should be MHC class I restricted in their
cell-cell interactions. We were able to demonstrate that CD8' lymphocytes were1432
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incapable of inhibiting viral replication in PBL of MHC class I-mismatched
SIVma,-infected monkeys. However, MHC class I-matched unrelated SIVrt,ac-
infected monkeys were not available for study. Thus, we could not formally prove
that MHC class I matching between the CD8' cell population and the CD8' lym-
phocyte-depleted PBL was sufficient to facilitate an inhibitory interaction. How-
ever, these findings are consistent with our previous observation that a long-term
T lymphocyte line, generated from rhesus monkey PBL by repeated in vitro stimu-
lation with autologous SIVa,-infected cells in the presence of IL-2, inhibited SIVma,
replication in CD8' lymphocyte-depleted autologous lymphocytes, but not in CD8'
lymphocyte-depleted cells from a MHC class I-mismatched animal (14). These ex-
periments together demonstrate, within the limitations ofourexperimental systems,
that the interactions of this CD8' lymphocyte population may be MHC class I re-
stricted .
Thus, these studies provide evidence that the CD8' inhibitory cells may be an-
tigen specific and MHC class I restricted. These findings, coupledwith the observa-
tion that the inhibitory cells are S6F1+ and the demonstration that this inhibitory
function canbe blockedboth withanti-LFA-1 and anti-CD8 mAbs, provide compel-
ling evidence that this CD8' cell is, in fact, a CTL.
The observation that the inhibitory CD8' cell is phenotypically a CTL makes
the studies with the mAbs anti-2114 and anti-4134 particularly interesting. While
previous workwith these mAbs indicates that CD4' cells can be divided into pheno-
typically and functionally distinct groups that subserve either helper function or in-
ducer of suppression function (24, 25), little work has been done with these anti-
bodies in the study of CD8' lymphocytes. The current experiments suggest that
functional virus-specific cytotoxic cells may be contained only within the 4B4'2H4-
subpopulation of CD8' lymphocytes.
While these studies indicate that the cell which inhibits HIV-1 and SIV,nac repli-
cation in PBL is phenotypically a CTL, the mechanism by which this CD8' lym-
phocyte inhibits the replication of virus remains to be elucidated. Cell contact is
required between the CD8' lymphocyte and cells harboring replicating virus since
this inhibitory process can be blocked by anti-LFA-1 and anti-CD8 mAbs. It is not
clear, however, whether this cell contact is necessaryonly forthe triggering offactor
secretion by these CD8' cells, which in turn inhibits virus replication, or whether
this CD8' cell, in fact, lyses the AIDS virus-expressing target cell. It is interesting
to speculate that this AIDS virus-inhibiting cell might represent the same subset
oflymphocytes in PBL capable of lysing autologous AIDS virus-expressing target
cells (3-5).
Summary
CD8' (suppressor/cytotoxic) lymphocytes block replication of HIV-1 or the
simian immunodeficiency virus of macaques (SIVma~) in PBL of infected individ-
uals. We now show that these CD8' lymphocytes undergo clonal expansion in vivo
after AIDSvirusinfection ofthe individual, suggesting they maybeantigen-specific
T cells. These CD8' cells block replication of virus in autologous but not MHC
class I-mismatched PBL. The inhibitory lymphocytes express the integrin family
molecule 4B4 andthe CTL-associated S6F1 epitope ofLFA-1. Finally, physical con-
tact is required for the CD8' lymphocyte-mediated inhibition ofAIDS virus repli-TSUBOTA ET AL.
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cation, since this inhibitory function is blocked by anti-LFA-1 and anti-CD8 rnAbs.
These studies suggest that the cell that inhibits AIDS virus replication in PBL of
infected individuals is a CTL.
We thank M . Hirsch and J. Sullivan for providing blood samples from HIV-1-infected pa-
tients and D. Brosseau for preparation of this manuscript.
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